4//SEC Filing
MCAFEE LAWRANCE W 4
Accession 0001209191-19-045468
CIK 0000885978other
Filed
Aug 11, 8:00 PM ET
Accepted
Aug 12, 2:25 PM ET
Size
7.6 KB
Accession
0001209191-19-045468
Insider Transaction Report
Form 4
MCAFEE LAWRANCE W
DirectorChief Financial Officer
Transactions
- Sale
Common Stock
2019-08-09$132.53/sh−1,200$159,036→ 23,028 total - Sale
Common Stock
2019-08-09$130.55/sh−1,300$169,715→ 21,728 total
Footnotes (3)
- [F1]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $132.02 to $133.45 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
- [F2]Includes 19,898 shares of restricted stock granted under the Company's equity plans. Restrictions lapse as to 2,500 shares on each of October 1, 2019 and January 1, 2020; 1,790 shares on each of April 1, July 1 and October 1, 2020; 1,805 shares on January 1, 2021; 1,280 shares on each of April 1, July 1 and October 1, 2021; 1,288 on January 1, 2022; 648 on each of April 1, July 1 and October 1, 2022; and 651 on January 1, 2023.
- [F3]The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $130.07 to $131.01 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Documents
Issuer
U S PHYSICAL THERAPY INC /NV
CIK 0000885978
Entity typeother
Related Parties
1- filerCIK 0001263096
Filing Metadata
- Form type
- 4
- Filed
- Aug 11, 8:00 PM ET
- Accepted
- Aug 12, 2:25 PM ET
- Size
- 7.6 KB